2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 16:32 (4332 d 06:06 ago) – Posting: # 11336
Views: 45,545

Hi HS

❝ Followed by:

❝ If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.

❝ … provided that the group meets minimum requirements for a complete bioequivalence study.


According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
37 visitors (0 registered, 37 guests [including 15 identified bots]).
Forum time: 22:38 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5